Compare DexCom, Inc. (DXCM) vs EHang Holdings Ltd - ADR (EH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs EHang Holdings Ltd - ADR — how do they compare? DexCom, Inc. trades at $90.64 (market cap $33.79B), while EHang Holdings Ltd - ADR trades at $5.79 (market cap $437.63M). The key difference: DexCom, Inc. is far larger — about 77.2× EHang Holdings Ltd - ADR's market cap, and DexCom, Inc. is trading nearer its 52-week high, EHang Holdings Ltd - ADR nearer its low. Which is the better fit depends on your goals.
| DXCM | EH | |
|---|---|---|
Market Cap | $33.79B | $437.63M |
Sector | Health | Industrials |
52-Week High | $89.53 | $19.44 |
52-Week Low | $54.84 | $4.90 |
Enterprise Value | $33.24B | $376.84M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $91.00, up 3.82% today and near its 52-week high, with bullish technical signals from moving averages and strong fundamentals. Recent Q2 2026 earnings beat expectations with EPS of $0.70 versus $0.61 expected, driven by 13% revenue growth and margin expansion. The company raised full-year 2026 guidance, reflecting robust demand for continuous glucose monitors.
The outlook is positive due to sustained revenue growth, profitability improvements, and analyst consensus favoring buys. Risks include competitive pressures and potential regulatory scrutiny, but institutional ownership trends and earnings momentum support a constructive view for investors seeking exposure to medical technology.
EHang Holdings (EH) trades at $5.70, up 0.18% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported Q1 2026 revenue of $418 million, with a net loss of $276 million, reflecting ongoing profitability challenges despite a high gross margin of 61.53%. Recent news includes the successful pilotless eVTOL flight in Kazakhstan, highlighting operational progress amid a volatile year for air taxi stocks.
The outlook remains speculative, with significant growth potential in the advanced air mobility market offset by persistent losses and competitive pressures. Risks include execution hurdles and funding needs, while analyst sentiment is divided with a consensus price target of $6.97 suggesting modest upside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About EHang Holdings Ltd - ADR
EHang Holdings Ltd is an autonomous aerial vehicle (AAV) technology platform company. It focuses on making safe, autonomous and eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with AAV products and commercial solutions: air mobility (including passenger transportation and logistics), smart city management and aerial media solutions. As the forerunner of cutting-edge AAV technologies and commercial solutions in the global Urban Air Mobility industry, it continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.
Read more on EH →
